Status:
COMPLETED
Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Dyslipidemias
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the efficacy of atorvastatin in lowering cholesterol on patients from Thailand with high cholesterol.
Eligibility Criteria
Inclusion
- Dyslipidemic patients who were eligible for lipid lowering therapy
- Willingness to follow study diet for 1 month prior to screening and for the duration of the study
Exclusion
- Use of other lipid lowering agents (6-week washout period)
- Uncontrolled high blood pressure
- Impaired liver function
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2004
Estimated Enrollment :
242 Patients enrolled
Trial Details
Trial ID
NCT00647543
Start Date
August 1 2003
End Date
April 1 2004
Last Update
February 18 2021
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Bangkok, Thailand, 10400
2
Pfizer Investigational Site
Bangkok, Thailand, 10700
3
Pfizer Investigational Site
Chiang Mai, Thailand, 50200
4
Pfizer Investigational Site